Literature DB >> 27248362

Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ.

J Scott Miners1, Polly Clarke1, Seth Love1.   

Abstract

Clusterin, also known as apoJ, is a lipoprotein abundantly expressed within the CNS. It regulates Aβ fibril formation and toxicity and facilitates amyloid-β (Aβ) transport across the blood-brain barrier. Genome-wide association studies have shown variations in the clusterin gene (CLU) to influence the risk of developing sporadic Alzheimer's disease (AD). To explore whether clusterin modulates the regional deposition of Aβ, we measured levels of soluble (NP40-extracted) and insoluble (guanidine-HCl-extracted) clusterin, Aβ40 and Aβ42 by sandwich ELISA in brain regions with a predilection for amyloid pathology-mid-frontal cortex (MF), cingulate cortex (CC), parahippocampal cortex (PH), and regions with little or no pathology-thalamus (TH) and white matter (WM). Clusterin level was highest in regions with plaque pathology (MF, CC, PH and PC), approximately mirroring the regional distribution of Aβ. It was significantly higher in AD than controls, and correlated positively with Aβ42 and insoluble Aβ40. Soluble clusterin level rose significantly with severity of cerebral amyloid angiopathy, and in MF and PC regions was highest in APOE ɛ4 homozygotes. In the TH and WM (areas with little amyloid pathology) clusterin was unaltered in AD and did not correlate with Aβ level. There was a significant positive correlation between the concentration of clusterin and the regional levels of insoluble Aβ42; however, the molar ratio of clusterin : Aβ42 declined with insoluble Aβ42 level in a region-dependent manner, being lowest in regions with predilection for Aβ plaque pathology. Under physiological conditions, clusterin reduces aggregation and promotes clearance of Aβ. Our findings indicate that in AD, clusterin increases, particularly in regions with most abundant Aβ, but because the increase does not match the rising level of Aβ42, the molar ratio of clusterin : Aβ42 in those regions falls, probably contributing to Aβ deposition within the tissue.
© 2016 International Society of Neuropathology.

Entities:  

Keywords:  Alzheimer's disease; amyloid-β; amyloid-β clearance; apoJ; cerebral amyloid angiopathy; clusterin; plaque

Mesh:

Substances:

Year:  2016        PMID: 27248362      PMCID: PMC8029153          DOI: 10.1111/bpa.12392

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  62 in total

Review 1.  The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.

Authors:  Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-01-25       Impact factor: 5.590

2.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.

Authors:  Lars Bertram; Matthew B McQueen; Kristina Mullin; Deborah Blacker; Rudolph E Tanzi
Journal:  Nat Genet       Date:  2007-01       Impact factor: 38.330

3.  Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation.

Authors:  Mitsuru Shinohara; Ronald C Petersen; Dennis W Dickson; Guojun Bu
Journal:  Acta Neuropathol       Date:  2013-01-31       Impact factor: 17.088

4.  Apolipoprotein J and Alzheimer's amyloid beta solubility.

Authors:  E Matsubara; C Soto; S Governale; B Frangione; J Ghiso
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

Review 5.  In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology.

Authors:  David M Holtzman
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

6.  Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress.

Authors:  T Oda; P Wals; H H Osterburg; S A Johnson; G M Pasinetti; T E Morgan; I Rozovsky; W B Stine; S W Snyder; T F Holzman
Journal:  Exp Neurol       Date:  1995-11       Impact factor: 5.330

7.  ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo.

Authors:  Ronald B DeMattos; John R Cirrito; Maia Parsadanian; Patrick C May; Mark A O'Dell; Jennie W Taylor; Judith A K Harmony; Bruce J Aronow; Kelly R Bales; Steven M Paul; David M Holtzman
Journal:  Neuron       Date:  2004-01-22       Impact factor: 17.173

8.  Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases.

Authors:  Lucinda Craggs; Julie Taylor; Janet Y Slade; Aiqing Chen; Christian Hagel; Gregor Kuhlenbaeumer; Anne Borjesson-Hanson; Matti Viitanen; Hannu Kalimo; Vincent Deramecourt; Arthur E Oakley; Raj N Kalaria
Journal:  Neuropathol Appl Neurobiol       Date:  2015-06-17       Impact factor: 8.090

9.  Clusterin associates specifically with Aβ40 in Alzheimer's disease brain tissue.

Authors:  David R Howlett; Tibor Hortobágyi; Paul T Francis
Journal:  Brain Pathol       Date:  2013-04-21       Impact factor: 6.508

10.  Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease.

Authors:  Tammie L S Benzinger; Tyler Blazey; Clifford R Jack; Robert A Koeppe; Yi Su; Chengjie Xiong; Marcus E Raichle; Abraham Z Snyder; Beau M Ances; Randall J Bateman; Nigel J Cairns; Anne M Fagan; Alison Goate; Daniel S Marcus; Paul S Aisen; Jon J Christensen; Lindsay Ercole; Russ C Hornbeck; Angela M Farrar; Patricia Aldea; Mateusz S Jasielec; Christopher J Owen; Xianyun Xie; Richard Mayeux; Adam Brickman; Eric McDade; William Klunk; Chester A Mathis; John Ringman; Paul M Thompson; Bernardino Ghetti; Andrew J Saykin; Reisa A Sperling; Keith A Johnson; Stephen Salloway; Stephen Correia; Peter R Schofield; Colin L Masters; Christopher Rowe; Victor L Villemagne; Ralph Martins; Sebastien Ourselin; Martin N Rossor; Nick C Fox; David M Cash; Michael W Weiner; David M Holtzman; Virginia D Buckles; Krista Moulder; John C Morris
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-05       Impact factor: 11.205

View more
  27 in total

Review 1.  Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration.

Authors:  Wesley Peng; Georgia Minakaki; Maria Nguyen; Dimitri Krainc
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 2.  Exploring the Role of CLU in the Pathogenesis of Alzheimer's Disease.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Mst Marium Begum; Md Siddiqul Islam; Tapan Behl; Ghulam Md Ashraf
Journal:  Neurotox Res       Date:  2020-08-21       Impact factor: 3.911

3.  Isotopic N,N-dimethyl leucine tags for absolute quantification of clusterin and apolipoprotein E in Alzheimer's disease.

Authors:  Yuan Liu; Hua Zhang; Xiaofang Zhong; Zihui Li; Henrik Zetterberg; Lingjun Li
Journal:  J Proteomics       Date:  2022-02-03       Impact factor: 4.044

4.  Clusterin Binding Modulates the Aggregation and Neurotoxicity of Amyloid-β(1-42).

Authors:  Yun-Mi Kim; SuJi Park; Su Yeon Choi; Shin Bi Oh; MinKyo Jung; Chan-Gi Pack; Jung Jin Hwang; Eunyoung Tak; Joo-Yong Lee
Journal:  Mol Neurobiol       Date:  2022-07-29       Impact factor: 5.682

5.  Clusterin Is Associated with Systemic and Synovial Inflammation in Knee Osteoarthritis.

Authors:  Tachatra Ungsudechachai; Sittisak Honsawek; Jiraphun Jittikoon; Wanvisa Udomsinprasert
Journal:  Cartilage       Date:  2020-09-11       Impact factor: 3.117

Review 6.  Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.

Authors:  Steven M Greenberg; Brian J Bacskai; Mar Hernandez-Guillamon; Jeremy Pruzin; Reisa Sperling; Susanne J van Veluw
Journal:  Nat Rev Neurol       Date:  2019-12-11       Impact factor: 42.937

7.  Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis.

Authors:  Liana G Apostolova; Shannon L Risacher; Tugce Duran; Eddie C Stage; Naira Goukasian; John D West; Triet M Do; Jonathan Grotts; Holly Wilhalme; Kwangsik Nho; Meredith Phillips; David Elashoff; Andrew J Saykin
Journal:  JAMA Neurol       Date:  2018-03-01       Impact factor: 18.302

Review 8.  Autophagy and Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Implications.

Authors:  Md Sahab Uddin; Anna Stachowiak; Abdullah Al Mamun; Nikolay T Tzvetkov; Shinya Takeda; Atanas G Atanasov; Leandro B Bergantin; Mohamed M Abdel-Daim; Adrian M Stankiewicz
Journal:  Front Aging Neurosci       Date:  2018-01-30       Impact factor: 5.750

9.  Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer's Disease in a Central European Population.

Authors:  Vladimir J Balcar; Tomáš Zeman; Vladimír Janout; Jana Janoutová; Jan Lochman; Omar Šerý
Journal:  Neurochem Res       Date:  2020-11-18       Impact factor: 3.996

10.  Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease.

Authors:  J Scott Miners; Isabel Schulz; Seth Love
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-02       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.